To access subsidised CGM and Flash GM products through the NDSS, the person will need to see an authorised health professional to determine whether they meet the eligibility criteria and decide which is the most suitable product for them to use as part of their diabetes management. Not all products are suitable for everyone. Eligibility criteria All people with type 1 diabetes are eligible to apply for access to subsidised CGM and Flash GM products through the NDSS, as well as some people with other rare conditions that are similar to type 1 diabetes. Some people are eligible to access fully subsidised CGM and Flash GM products (that is, no co-payment will be required), while other people can access with a co-payment. You can access details and information about eligibility from these links: Children and young people aged under 21 years with type 1 diabetes Children and young people under 21 years with conditions very similar to type 1 diabetes who require insulin People with type 1 diabetes aged 21 years or older who have valid concessional status Women with type 1 diabetes who are actively planning pregnancy, pregnant, or immediately post-pregnancy Submitting a standard application To submit an application, a completed Continuous and Flash Glucose Monitoring Access form prepared and certified by an authorised health professional, should be: emailed to the NDSS at [email protected] (preferred option), or posted to GPO Box 9824 in your capital city, or faxed to 1300 536 953. Download a Continuous and Flash Glucose Monitoring Access form. Some Continuous and Flash Glucose Monitoring Access forms can be completed online through the NDSS Health Professional Portal. Forms can be processed, and access confirmed within minutes if all required information is supplied. Resources Continuous and flash glucose monitoring booklet Continuous and flash glucose monitoring devices An information booklet for health professionals about subsidised continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) devices through the NDSS. Download Indications for use The CGM and Flash GM device summary and compatibility chart contains information about CGM and Flash GM devices fully subsidised through the NDSS, their compatibility with insulin pumps and smartphone and smart devices, and links to guidelines about appropriate use, including manufacturers documentation. The Therapeutic Goods Administration approves CGM and Flash GM devices that can be lawfully supplied in Australia and these are listed in the Australian Register of Therapeutic Goods (ARTG). By certifying Continuous and Flash Glucose Monitoring Access forms for a person, you are confirming that you are aware that not all CGM and Flash GM products are indicated for use in all conditions or all age groups, and that you have considered available advice about the selected device. This includes advice on the relevant ARTG listing about appropriate use for specific conditions. The CGM and Flash GM device summary and compatibility chart contains links to the ARTG listings. CGM and Flash GM device summary and compatibility chart This resource has information about the devices subsidised through the NDSS, their compatibility with insulin pumps and smartphone and smart devices, and links to guidelines about appropriate use. Download Submitting an extended access application Women with type 1 diabetes actively planning pregnancy are eligible for access to CGM and Flash GM products for a period up to 12 months (initial period of 6 months with a subsequent period of an additional 6 months on confirmation—by an authorised health professional—that pre-pregnancy care is continuing). Sometimes pregnancy planning may need to continue after the initial 12 months. Find out more about: Applying for extended access to CGM and Flash GM products (for planning pregnancy in type 1 diabetes) Related resources Continuous and flash glucose monitoring Applying for extended access to CGM or Flash GM products (for planning pregnancy in type 1 diabetes)
